200122-33-4

Upstream product

• 24310-36-9 1-tosyl-2,3,4,5-tetrahydro-1H-1-benzazepin-5-one 
• 50998-74-8 methyl N-tosylanthranilate 
• 122-04-3 4-nitro-benzoyl chloride 
• 1261276-90-7 C₁₃H₁₀BrNO₂S 
• 153894-28-1 2-carbethoxy-4,5,6-trihydro-6-tosylthiopheno<3,2-d><1>benzazepin 
• 153894-24-7 5-chloro-1-tosyl-2,3-dihydro-1H-benzo[b]azepine-4-carbaldehyde 
• 100627-39-2 N-(3-ethoxycarbonyl-propyl)-N-(toluene-4-sulfonyl)-anthranilic acid methyl ester 
• 134-20-3 2-carbomethoxyaniline 
• 1261277-05-7 ethyl 5,6-dihydro-4H-benzo[b]thieno[2,3-d]azepine-2-carboxylate hydrochloride 
• 200122-32-3 5-chloro-1-(4-nitrobenzoyl)-2,3-dihydro-1 H-benzo[b]azepine-4-carbaldehyde 
• 623-51-8 ethyl 2-sulfanylacetate 
• 1127-74-8 1,2,3,4-tetrahydro-5H-benzo[b] azepin-5-one 
• 137975-89-4 1-(4-nitrobenzoyl)-2,3,4,5-tetrahydro-1H-1-benzazepin-5-one 

Downstream Products

• 200122-34-5 ethyl 6-(4-aminobenzoyl)-5,6-dihydro-4H-benzo[b]thieno[2,3-d]azepine-2-carboxylate 
• 1261276-49-6 C₃₅H₃₁N₅O₃S₂ 
• 1261277-08-0 C₂₈H₂₂BrN₃O₄S 
• 1261277-10-4 C₃₂H₃₀N₄O₄S 
• 1261277-12-6 C₃₀H₂₅N₄O₄S^(1-)*Na⁽¹⁺⁾ 
• 200122-35-6 6-(4-nitrobenzoyl)-5,6-dihydro-4H-benzo[b]thieno[2,3-d]azepine-2-carboxylic acid 

Relevant academic research and scientific papers

HETEROCYCLIC COMPOUNDS AS RSV INHIBITORS

The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit Respiratory Syncytial Virus (RSV). The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from RSV infection. The invention also relates to methods of treating an RSV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.

HETEROCYCLIC COMPOUNDS AS RSV INHIBITORS

The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: Formula (I) which inhibit Respiratory Syncytial Virus (RSV). The present invention further relates to pharmaceutical compositions

4,5-DIHYDRO-6H-THIENO[3,2-D]BENZAZEPINE DERIVATIVES AND THEIR USE TO TREAT RESPIRATORY SYNCYTIAL VIRUS (RSV) INFECTIONS

There are provided inter alia compounds which are intended to treat or prevent respiratory syncytial virus infections and associated disease particularly infections caused by the A and B strains thereof.

Novel 5,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivative

There is provided a 5,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivative which is useful in the treatment of respiratory syncytial virus (RSV) infection and for the prevention of disease associated with RSV infection. (Formula (I))

ANTI-RSV COMPOUNDS

The present invention relates to anti-RSV compounds of Formula (I) and methods for use of the compounds in the treatment and prevention of RSV infection.